1 min read
Add as a preferred source on Google

Ginkgo Bioworks Posts $27.7 Million in Q3 Revenue, Reaffirms 2026 Cash-Burn Outlook

The company recorded a $0.64 GAAP loss per share, $0.22 better than estimates, while revenue exceeded estimates by $6.19 million.

A stainless-steel bioreactor stands in a quiet laboratory / TokenPost.ai
A stainless-steel bioreactor stands in a quiet laboratory / TokenPost.ai

Ginkgo Bioworks Holdings, Inc. posted third-quarter revenue of $27.7 million, down 5.7% from a year earlier, and reaffirmed its full-year 2026 outlook for total cash burn of $125 million to $150 million.

GAAP loss per share was $0.64, $0.22 better than estimates. Revenue exceeded estimates by $6.19 million.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…